» Articles » PMID: 12557293

Lack of Creatine in Muscle and Brain in an Adult with GAMT Deficiency

Overview
Journal Ann Neurol
Specialty Neurology
Date 2003 Jan 31
PMID 12557293
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Guanidinoacetate methyltransferase deficiency, which so far has been exclusively detected in children, was diagnosed in a 26-year-old man. The full-blown spectrum of clinical symptoms already had been present since infancy without progression of symptoms during adolescence. Cranial magnetic resonance imaging showed normal findings. Ophthalmological examination showed no retinal changes. Besides creatine deficiency in the brain, a distinct lack of phosphocreatine in skeletal muscle was proved by (31)P magnetic resonance spectroscopy. Creatine substitution combined with a guanidinoacetate-lowering diet introduced first at the age of 26 years was shown to be effective by an impressive improvement of epileptic seizures, mental capabilities, and general behavior and by normalization of the (31)P spectrum in the skeletal muscle.

Citing Articles

Validation and Optimization of a Stable Isotope-Labeled Substrate Assay for Measuring AGAT Activity.

Lee A, Anderson L, Tkachyova I, Tropak M, Wang D, Schulze A Int J Mol Sci. 2024; 25(23).

PMID: 39684202 PMC: 11641458. DOI: 10.3390/ijms252312490.


Phenotypic and Molecular Spectrum of Guanidinoacetate N-Methyltransferase Deficiency: An Analytical Study of a Case Series and a Scoping Review of 53 Cases of Guanidinoacetate N-Methyltransferase.

Alyazidi A, Muthaffar O, Shawli M, Ahmed R, Aljefri Y, Baaishrah L J Microsc Ultrastruct. 2024; 12(2):81-90.

PMID: 39006040 PMC: 11245129. DOI: 10.4103/jmau.jmau_16_22.


Creatinine, cystatin C, muscle mass, and mortality: Findings from a primary and replication population-based cohort.

Groothof D, Shehab N, Erler N, Post A, Kremer D, Polinder-Bos H J Cachexia Sarcopenia Muscle. 2024; 15(4):1528-1538.

PMID: 38898741 PMC: 11294032. DOI: 10.1002/jcsm.13511.


Rescue of myocytes and locomotion through intracisternal gene therapy in a rat model of creatine transporter deficiency.

Fernandes-Pires G, Azevedo M, Lanzillo M, Roux-Petronelli C, Binz P, Cudalbu C Mol Ther Methods Clin Dev. 2024; 32(2):101251.

PMID: 38745894 PMC: 11091509. DOI: 10.1016/j.omtm.2024.101251.


GAMT Deficiency Among Pediatric Population: Clinical and Molecular Characteristics and Management.

Almaghrabi M, Muthaffar O, Alahmadi S, Abdulsbhan M, Bamusa M, Aljezani M Child Neurol Open. 2023; 10:2329048X231215630.

PMID: 38020815 PMC: 10655665. DOI: 10.1177/2329048X231215630.